# HubSpot timeline

entity: /record/hubspot.md  
id: ent_hubspot  


## undated

- undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_376344CF53EC](/claim/clm_376344CF53EC.md)
- undated | fiscal_year_end | 12-31 | valid | [clm_4D0E6F4878A7](/claim/clm_4D0E6F4878A7.md)
- undated | registrant_name | HUBSPOT INC | valid | [clm_7C7A4D525249](/claim/clm_7C7A4D525249.md)
- undated | state_of_incorporation | NY | valid | [clm_7D712838A51F](/claim/clm_7D712838A51F.md)
- undated | cik | 0001404655 | valid | [clm_96E2A8414E91](/claim/clm_96E2A8414E91.md)
- undated | ticker | HUBS | valid | [clm_9B382EACD452](/claim/clm_9B382EACD452.md)
- undated | listed_on | NYSE | valid | [clm_F07EC4D0F0D0](/claim/clm_F07EC4D0F0D0.md)
- undated | produces | customer retention | unverified | [clm_06CFF94C25AD](/claim/clm_06CFF94C25AD.md)
- undated | industry | analytics | unverified | [clm_0D7CCBD2CF1F](/claim/clm_0D7CCBD2CF1F.md)
- undated | produces | marketing automation | unverified | [clm_0D944A9B2F35](/claim/clm_0D944A9B2F35.md)
- undated | owner_of | PieSync | unverified | [clm_0EBAF79A6244](/claim/clm_0EBAF79A6244.md)
- undated | x_username | HubSpot | unverified | [clm_14AE2ABFD2A3](/claim/clm_14AE2ABFD2A3.md)
- undated | produces | content creation | unverified | [clm_17F49DE2E375](/claim/clm_17F49DE2E375.md)
- undated | founder | Brian Halligan | valid | [clm_1B2B4A0ACF53](/claim/clm_1B2B4A0ACF53.md)
- undated | produces | customer relationship management software | unverified | [clm_2FF7F7D698DA](/claim/clm_2FF7F7D698DA.md)
- undated | produces | email marketing | unverified | [clm_304642745962](/claim/clm_304642745962.md)
- undated | produces | artificial intelligence | unverified | [clm_36EA4C167483](/claim/clm_36EA4C167483.md)
- undated | legal_form | corporation | unverified | [clm_3B7E0FFBEDCF](/claim/clm_3B7E0FFBEDCF.md)
- undated | produces | Net Promoter Score | unverified | [clm_3B8168E23DAA](/claim/clm_3B8168E23DAA.md)
- undated | owner_of | Mindstream | unverified | [clm_4A29F24EB2BC](/claim/clm_4A29F24EB2BC.md)
- undated | website | http://www.hubspot.com | unverified | [clm_529267A58325](/claim/clm_529267A58325.md)
- undated | founder | Dharmesh Shah | valid | [clm_56DE99226D7D](/claim/clm_56DE99226D7D.md)
- undated | produces | lead generation | unverified | [clm_579AA50AA93D](/claim/clm_579AA50AA93D.md)
- undated | produces | customer data platform | unverified | [clm_602CE7C17D8D](/claim/clm_602CE7C17D8D.md)
- undated | produces | data visualization software | unverified | [clm_72677B6B2307](/claim/clm_72677B6B2307.md)
- undated | industry | software as a service | unverified | [clm_7B72C230B64E](/claim/clm_7B72C230B64E.md)
- undated | produces | cloud computing | unverified | [clm_8BBB601F5DAE](/claim/clm_8BBB601F5DAE.md)
- undated | legal_form | Delaware corporation | unverified | [clm_8E4AE1197D05](/claim/clm_8E4AE1197D05.md)
- undated | produces | e-commerce | unverified | [clm_9179809F52DD](/claim/clm_9179809F52DD.md)
- undated | industry | automation | unverified | [clm_9CD07C2C6F1F](/claim/clm_9CD07C2C6F1F.md)
- undated | legal_form | public company | unverified | [clm_A0275135292C](/claim/clm_A0275135292C.md)
- undated | produces | automation technology | unverified | [clm_A45FB860F84B](/claim/clm_A45FB860F84B.md)
- undated | industry | customer relationship management | unverified | [clm_A7C697AD0ED3](/claim/clm_A7C697AD0ED3.md)
- undated | produces | business-to-business | unverified | [clm_A802F588C573](/claim/clm_A802F588C573.md)
- undated | owner_of | Dashworks | unverified | [clm_AAE6FBA7CC92](/claim/clm_AAE6FBA7CC92.md)
- undated | owner_of | Cacheflow | unverified | [clm_AD0AFA258A9F](/claim/clm_AD0AFA258A9F.md)
- undated | produces | top-line growth | unverified | [clm_B4CF85A3C583](/claim/clm_B4CF85A3C583.md)
- undated | industry | email marketing | unverified | [clm_BCA7C0F93AD2](/claim/clm_BCA7C0F93AD2.md)
- undated | produces | Sales development | unverified | [clm_C08CAC19879F](/claim/clm_C08CAC19879F.md)
- undated | industry | marketing | unverified | [clm_C16739F99415](/claim/clm_C16739F99415.md)
- undated | member_of | Business Software Alliance | unverified | [clm_C27BF62822E6](/claim/clm_C27BF62822E6.md)
- undated | industry | cloud computing | unverified | [clm_C62DE1159184](/claim/clm_C62DE1159184.md)
- undated | produces | Sales software | unverified | [clm_CED8FFB45099](/claim/clm_CED8FFB45099.md)
- undated | produces | enterprise resource planning | unverified | [clm_E754D86256DC](/claim/clm_E754D86256DC.md)
- undated | owner_of | The Hustle | unverified | [clm_E8AAB4E8B95F](/claim/clm_E8AAB4E8B95F.md)
- undated | owner_of | Frame AI | unverified | [clm_E95A3F65D71B](/claim/clm_E95A3F65D71B.md)
- undated | produces | application programming interface | unverified | [clm_EEF66E89951A](/claim/clm_EEF66E89951A.md)
- undated | produces | analytics | unverified | [clm_F8B9CF78BF7A](/claim/clm_F8B9CF78BF7A.md)
- undated | produces | live chat | unverified | [clm_F91B256E8C25](/claim/clm_F91B256E8C25.md)

## 2008

- 2008-04-20 | x_username | hubspot | unverified | [clm_E5C7F84AF6CD](/claim/clm_E5C7F84AF6CD.md)

## 2011

- 2011-12-31 to 2012-12-31 | total_equity | -47,702,000 United States dollar | superseded | [clm_6A277EBBD95B](/claim/clm_6A277EBBD95B.md)
- 2011-12-31 to 2012-12-31 | cash_and_equivalents | 13,972,000 United States dollar | superseded | [clm_F0A63D90A16C](/claim/clm_F0A63D90A16C.md)

## 2012

- 2012-12-31 to 2013-12-31 | research_and_development | 10,585,000 United States dollar | superseded | [clm_36CA2A64A6F8](/claim/clm_36CA2A64A6F8.md)
- 2012-12-31 to 2013-12-31 | cash_and_equivalents | 41,097,000 United States dollar | superseded | [clm_68203D5B3EB8](/claim/clm_68203D5B3EB8.md)
- 2012-12-31 to 2013-12-31 | total_equity | -63,209,000 United States dollar | superseded | [clm_76FEB9F0476F](/claim/clm_76FEB9F0476F.md)
- 2012-12-31 to 2013-12-31 | net_income | -18,778,000 United States dollar | superseded | [clm_A22AE408334D](/claim/clm_A22AE408334D.md)
- 2012-12-31 to 2013-12-31 | revenue | 51,604,000 United States dollar | superseded | [clm_FBB07ECA179B](/claim/clm_FBB07ECA179B.md)

## 2013

- 2013-09-30 to 2014-03-31 | quarterly_net_income | -9,511,000 United States dollar | superseded | [clm_13D13DD0FD81](/claim/clm_13D13DD0FD81.md)
- 2013-09-30 to 2014-03-31 | quarterly_research_and_development | 4,271,000 United States dollar | superseded | [clm_E33715379C6F](/claim/clm_E33715379C6F.md)
- 2013-09-30 to 2014-03-31 | quarterly_revenue | 20,179,000 United States dollar | superseded | [clm_EDA1E69F9013](/claim/clm_EDA1E69F9013.md)
- 2013-12-31 to 2014-12-31 | net_income | -34,274,000 United States dollar | superseded | [clm_26691C8A2EC0](/claim/clm_26691C8A2EC0.md)
- 2013-12-31 to 2014-03-31 | cash_and_equivalents | 12,643,000 United States dollar | superseded | [clm_343B6BE99BD7](/claim/clm_343B6BE99BD7.md)
- 2013-12-31 to 2014-09-30 | total_assets | 50,559,000 United States dollar | superseded | [clm_5185ACEAA41C](/claim/clm_5185ACEAA41C.md)
- 2013-12-31 to 2014-09-30 | total_equity | -93,248,000 United States dollar | superseded | [clm_8CA8CC615781](/claim/clm_8CA8CC615781.md)
- 2013-12-31 to 2014-12-31 | revenue | 77,634,000 United States dollar | superseded | [clm_9A2DDF317B34](/claim/clm_9A2DDF317B34.md)
- 2013-12-31 to 2014-12-31 | research_and_development | 15,018,000 United States dollar | superseded | [clm_9F1B8160E815](/claim/clm_9F1B8160E815.md)
- 2013-12-31 to 2014-12-31 | operating_income | -34,250,000 United States dollar | superseded | [clm_A69A40BE54A6](/claim/clm_A69A40BE54A6.md)

## 2014

- 2014-03-31 to 2014-06-30 | quarterly_revenue | 24,174,000 United States dollar | superseded | [clm_06D5E3417826](/claim/clm_06D5E3417826.md)
- 2014-03-31 to 2014-06-30 | quarterly_research_and_development | 4,693,000 United States dollar | superseded | [clm_0E06FFEEB56B](/claim/clm_0E06FFEEB56B.md)
- 2014-03-31 to 2014-06-30 | quarterly_net_income | -9,465,000 United States dollar | superseded | [clm_218FABF83A49](/claim/clm_218FABF83A49.md)
- 2014-03-31 to 2014-06-30 | quarterly_operating_income | -9,414,000 United States dollar | superseded | [clm_5DC0C946E36D](/claim/clm_5DC0C946E36D.md)
- 2014-03-31 to 2014-06-30 | cash_and_equivalents | 7,967,000 United States dollar | superseded | [clm_69B634D3E93E](/claim/clm_69B634D3E93E.md)
- 2014-06-30 to 2014-09-30 | quarterly_revenue | 27,098,000 United States dollar | superseded | [clm_5698C9D744E6](/claim/clm_5698C9D744E6.md)
- 2014-06-30 to 2014-09-30 | cash_and_equivalents | 7,302,000 United States dollar | superseded | [clm_597169BF1976](/claim/clm_597169BF1976.md)
- 2014-06-30 to 2014-09-30 | quarterly_operating_income | -8,277,000 United States dollar | superseded | [clm_721EF3BD5587](/claim/clm_721EF3BD5587.md)
- 2014-06-30 to 2014-09-30 | quarterly_net_income | -8,279,000 United States dollar | superseded | [clm_BC1B465D45AE](/claim/clm_BC1B465D45AE.md)
- 2014-06-30 to 2014-09-30 | quarterly_research_and_development | 4,948,000 United States dollar | superseded | [clm_F012A86348E2](/claim/clm_F012A86348E2.md)
- 2014-09-30 to 2015-03-31 | quarterly_revenue | 30,448,000 United States dollar | superseded | [clm_04471CF9BDFE](/claim/clm_04471CF9BDFE.md)
- 2014-09-30 to 2014-12-31 | total_assets | 58,938,000 United States dollar | superseded | [clm_7D33E9F82FCF](/claim/clm_7D33E9F82FCF.md)
- 2014-09-30 to 2015-03-31 | quarterly_operating_income | -10,957,000 United States dollar | superseded | [clm_A12B74733B01](/claim/clm_A12B74733B01.md)
- 2014-09-30 to 2014-12-31 | total_equity | -115,078,000 United States dollar | superseded | [clm_B9F67DD6A546](/claim/clm_B9F67DD6A546.md)
- 2014-09-30 to 2015-03-31 | quarterly_net_income | -10,793,000 United States dollar | superseded | [clm_D793B5634895](/claim/clm_D793B5634895.md)
- 2014-09-30 to 2014-12-31 | cash_and_equivalents | 12,379,000 United States dollar | superseded | [clm_EBC8E625BAD3](/claim/clm_EBC8E625BAD3.md)
- 2014-09-30 to 2015-03-31 | quarterly_research_and_development | 4,858,000 United States dollar | superseded | [clm_FD0B16D3A3C8](/claim/clm_FD0B16D3A3C8.md)
- 2014-10-31 to 2015-02-27 | shares_outstanding | 31,390,213 shares | superseded | [clm_439BBC6957CE](/claim/clm_439BBC6957CE.md)
- 2014-12-31 to 2015-12-31 | net_income | -48,229,000 United States dollar | superseded | [clm_29463AA3648C](/claim/clm_29463AA3648C.md)
- 2014-12-31 to 2015-03-31 | cash_and_equivalents | 123,721,000 United States dollar | superseded | [clm_6FB5C18A0BC4](/claim/clm_6FB5C18A0BC4.md)
- 2014-12-31 to 2015-03-31 | total_equity | 110,699,000 United States dollar | superseded | [clm_7F1465616FC8](/claim/clm_7F1465616FC8.md)
- 2014-12-31 to 2015-03-31 | total_assets | 174,858,000 United States dollar | superseded | [clm_D558A435099D](/claim/clm_D558A435099D.md)
- 2014-12-31 to 2015-12-31 | revenue | 115,876,000 United States dollar | superseded | [clm_E333F092E6E3](/claim/clm_E333F092E6E3.md)
- 2014-12-31 to 2015-12-31 | research_and_development | 25,638,000 United States dollar | superseded | [clm_E8C985907DED](/claim/clm_E8C985907DED.md)
- 2014-12-31 to 2015-12-31 | operating_income | -48,609,000 United States dollar | superseded | [clm_F8FC79218B62](/claim/clm_F8FC79218B62.md)

## 2015

- 2015-02-27 to 2015-04-30 | shares_outstanding | 31,498,756 shares | superseded | [clm_7D181F27E70C](/claim/clm_7D181F27E70C.md)
- 2015-03-31 to 2015-06-30 | quarterly_research_and_development | 7,501,000 United States dollar | superseded | [clm_08902FDD79C9](/claim/clm_08902FDD79C9.md)
- 2015-03-31 to 2015-06-30 | quarterly_operating_income | -11,412,000 United States dollar | superseded | [clm_106EA47DBE62](/claim/clm_106EA47DBE62.md)
- 2015-03-31 to 2015-06-30 | cash_and_equivalents | 129,375,000 United States dollar | superseded | [clm_4FE71E9D12DA](/claim/clm_4FE71E9D12DA.md)
- 2015-03-31 to 2015-06-30 | quarterly_net_income | -10,858,000 United States dollar | superseded | [clm_62985608105F](/claim/clm_62985608105F.md)
- 2015-03-31 to 2015-06-30 | total_equity | 139,208,000 United States dollar | superseded | [clm_862722CD5A16](/claim/clm_862722CD5A16.md)
- 2015-03-31 to 2015-06-30 | quarterly_revenue | 38,166,000 United States dollar | superseded | [clm_B7BF5F667197](/claim/clm_B7BF5F667197.md)
- 2015-03-31 to 2015-06-30 | total_assets | 209,072,000 United States dollar | superseded | [clm_D4A10F1EFFFD](/claim/clm_D4A10F1EFFFD.md)
- 2015-04-30 to 2015-07-31 | shares_outstanding | 33,081,183 shares | superseded | [clm_4108351FA509](/claim/clm_4108351FA509.md)
- 2015-06-30 to 2015-09-30 | quarterly_operating_income | -11,322,000 United States dollar | superseded | [clm_001080B7BB1A](/claim/clm_001080B7BB1A.md)
- 2015-06-30 to 2015-09-30 | total_equity | 130,319,000 United States dollar | superseded | [clm_4EB8E234B7F4](/claim/clm_4EB8E234B7F4.md)
- 2015-06-30 to 2015-09-30 | quarterly_net_income | -11,392,000 United States dollar | superseded | [clm_61FBC4EF08CC](/claim/clm_61FBC4EF08CC.md)
- 2015-06-30 to 2015-09-30 | quarterly_research_and_development | 8,158,000 United States dollar | superseded | [clm_6597CA041B18](/claim/clm_6597CA041B18.md)
- 2015-06-30 to 2015-09-30 | total_assets | 208,857,000 United States dollar | superseded | [clm_7F6E6C64FA4B](/claim/clm_7F6E6C64FA4B.md)
- 2015-06-30 to 2015-09-30 | cash_and_equivalents | 74,235,000 United States dollar | superseded | [clm_86B1C77EC035](/claim/clm_86B1C77EC035.md)
- 2015-06-30 to 2015-09-30 | quarterly_revenue | 42,941,000 United States dollar | superseded | [clm_CB968221ECB3](/claim/clm_CB968221ECB3.md)
- 2015-07-31 to 2015-10-30 | shares_outstanding | 33,754,797 shares | superseded | [clm_8E793F56AC03](/claim/clm_8E793F56AC03.md)
- 2015-09-30 to 2016-03-31 | quarterly_operating_income | -13,290,000 United States dollar | superseded | [clm_43A968D9A75B](/claim/clm_43A968D9A75B.md)
- 2015-09-30 to 2016-03-31 | quarterly_net_income | -13,552,000 United States dollar | superseded | [clm_5AC0AEAAD92F](/claim/clm_5AC0AEAAD92F.md)
- 2015-09-30 to 2015-12-31 | total_equity | 124,174,000 United States dollar | superseded | [clm_68E22B3D433A](/claim/clm_68E22B3D433A.md)
- 2015-09-30 to 2016-03-31 | quarterly_revenue | 47,711,000 United States dollar | superseded | [clm_9CFC7D8B3B43](/claim/clm_9CFC7D8B3B43.md)
- 2015-09-30 to 2016-03-31 | quarterly_research_and_development | 8,128,000 United States dollar | superseded | [clm_AB9ED6B6CB49](/claim/clm_AB9ED6B6CB49.md)
- 2015-09-30 to 2015-12-31 | total_assets | 207,837,000 United States dollar | superseded | [clm_AE65D07FE0CC](/claim/clm_AE65D07FE0CC.md)
- 2015-09-30 to 2015-12-31 | cash_and_equivalents | 58,809,000 United States dollar | superseded | [clm_EFCD2F48004F](/claim/clm_EFCD2F48004F.md)
- 2015-10-30 to 2016-02-12 | shares_outstanding | 34,096,619 shares | superseded | [clm_5E7AB796DC49](/claim/clm_5E7AB796DC49.md)
- 2015-12-31 to 2016-12-31 | net_income | -46,053,000 United States dollar | superseded | [clm_27BB7D66C82C](/claim/clm_27BB7D66C82C.md)
- 2015-12-31 to 2016-12-31 | research_and_development | 32,457,000 United States dollar | superseded | [clm_43A42595F048](/claim/clm_43A42595F048.md)
- 2015-12-31 to 2016-03-31 | cash_and_equivalents | 55,580,000 United States dollar | superseded | [clm_CD61EAFAAA84](/claim/clm_CD61EAFAAA84.md)
- 2015-12-31 to 2016-12-31 | revenue | 181,943,000 United States dollar | superseded | [clm_E1F51A488D18](/claim/clm_E1F51A488D18.md)
- 2015-12-31 to 2016-03-31 | total_equity | 121,708,000 United States dollar | superseded | [clm_EFD9C2851492](/claim/clm_EFD9C2851492.md)
- 2015-12-31 to 2016-03-31 | total_assets | 220,379,000 United States dollar | superseded | [clm_F0A6FCCB5E2E](/claim/clm_F0A6FCCB5E2E.md)
- 2015-12-31 to 2016-12-31 | operating_income | -46,474,000 United States dollar | superseded | [clm_FB9A4CF7BA02](/claim/clm_FB9A4CF7BA02.md)

## 2016

- 2016-02-12 to 2016-04-29 | shares_outstanding | 34,707,673 shares | superseded | [clm_1BCC6E2F1F8A](/claim/clm_1BCC6E2F1F8A.md)
- 2016-03-31 to 2016-06-30 | quarterly_net_income | -10,154,000 United States dollar | superseded | [clm_402893527C50](/claim/clm_402893527C50.md)
- 2016-03-31 to 2016-06-30 | quarterly_research_and_development | 9,804,000 United States dollar | superseded | [clm_4145EB66019E](/claim/clm_4145EB66019E.md)
- 2016-03-31 to 2016-06-30 | quarterly_revenue | 58,960,000 United States dollar | superseded | [clm_6B60C0E6A451](/claim/clm_6B60C0E6A451.md)
- 2016-03-31 to 2016-06-30 | cash_and_equivalents | 53,019,000 United States dollar | superseded | [clm_B1819EF3C84A](/claim/clm_B1819EF3C84A.md)
- 2016-03-31 to 2016-06-30 | total_equity | 120,952,000 United States dollar | superseded | [clm_C78CCEFE792D](/claim/clm_C78CCEFE792D.md)
- 2016-03-31 to 2016-06-30 | quarterly_operating_income | -9,861,000 United States dollar | superseded | [clm_DF1BF7219781](/claim/clm_DF1BF7219781.md)
- 2016-03-31 to 2016-06-30 | total_assets | 229,992,000 United States dollar | superseded | [clm_FEB3F2B5BE9C](/claim/clm_FEB3F2B5BE9C.md)
- 2016-04-29 to 2016-07-29 | shares_outstanding | 34,943,502 shares | superseded | [clm_B72902756C17](/claim/clm_B72902756C17.md)
- 2016-06-30 to 2016-09-30 | quarterly_revenue | 64,974,000 United States dollar | superseded | [clm_8C887062EBB5](/claim/clm_8C887062EBB5.md)
- 2016-06-30 to 2016-09-30 | total_assets | 236,534,000 United States dollar | superseded | [clm_AAAEAE6965F1](/claim/clm_AAAEAE6965F1.md)
- 2016-06-30 to 2016-09-30 | quarterly_research_and_development | 11,278,000 United States dollar | superseded | [clm_B1B42A31244A](/claim/clm_B1B42A31244A.md)
- 2016-06-30 to 2016-09-30 | quarterly_net_income | -11,064,000 United States dollar | superseded | [clm_C01AEA8C17C2](/claim/clm_C01AEA8C17C2.md)
- 2016-06-30 to 2016-09-30 | quarterly_operating_income | -11,030,000 United States dollar | superseded | [clm_D0D2A9FB7EC8](/claim/clm_D0D2A9FB7EC8.md)
- 2016-06-30 to 2016-09-30 | total_equity | 120,452,000 United States dollar | superseded | [clm_D4A6A8D2235B](/claim/clm_D4A6A8D2235B.md)
- 2016-06-30 to 2016-09-30 | cash_and_equivalents | 58,661,000 United States dollar | superseded | [clm_F7650530EDC4](/claim/clm_F7650530EDC4.md)
- 2016-07-29 to 2016-10-28 | shares_outstanding | 35,346,218 shares | superseded | [clm_DEBCFE65B0DC](/claim/clm_DEBCFE65B0DC.md)
- 2016-09-30 to 2017-03-31 | quarterly_operating_income | -9,951,000 United States dollar | superseded | [clm_102F1AF30813](/claim/clm_102F1AF30813.md)
- 2016-09-30 to 2017-03-31 | quarterly_net_income | -10,515,000 United States dollar | superseded | [clm_235E43F0C661](/claim/clm_235E43F0C661.md)
- 2016-09-30 to 2016-12-31 | total_equity | 122,158,000 United States dollar | superseded | [clm_5A42BB3EDE90](/claim/clm_5A42BB3EDE90.md)
- 2016-09-30 to 2016-12-31 | cash_and_equivalents | 61,439,000 United States dollar | superseded | [clm_5FB817C181FC](/claim/clm_5FB817C181FC.md)
- 2016-09-30 to 2016-12-31 | total_assets | 247,786,000 United States dollar | superseded | [clm_A9C319B30BEB](/claim/clm_A9C319B30BEB.md)
- 2016-09-30 to 2017-03-31 | quarterly_research_and_development | 12,100,000 United States dollar | superseded | [clm_E01F3A3B02A5](/claim/clm_E01F3A3B02A5.md)
- 2016-09-30 to 2017-03-31 | quarterly_revenue | 70,589,000 United States dollar | superseded | [clm_FC57040141C2](/claim/clm_FC57040141C2.md)
- 2016-10-28 to 2017-02-10 | shares_outstanding | 35,608,553 shares | superseded | [clm_B79ABD7839E3](/claim/clm_B79ABD7839E3.md)
- 2016-12-31 to 2017-03-31 | total_assets | 259,755,000 United States dollar | superseded | [clm_4F69B809B12B](/claim/clm_4F69B809B12B.md)
- 2016-12-31 to 2017-03-31 | cash_and_equivalents | 59,702,000 United States dollar | superseded | [clm_8996161042FC](/claim/clm_8996161042FC.md)
- 2016-12-31 to 2017-12-31 | operating_income | -44,662,000 United States dollar | superseded | [clm_B0414FD27C7D](/claim/clm_B0414FD27C7D.md)
- 2016-12-31 to 2017-12-31 | net_income | -45,562,000 United States dollar | superseded | [clm_BE08FEAB64F2](/claim/clm_BE08FEAB64F2.md)
- 2016-12-31 to 2017-12-31 | research_and_development | 45,997,000 United States dollar | superseded | [clm_C5CAABCB3622](/claim/clm_C5CAABCB3622.md)
- 2016-12-31 to 2017-03-31 | total_equity | 118,700,000 United States dollar | superseded | [clm_E716040752DA](/claim/clm_E716040752DA.md)
- 2016-12-31 to 2017-12-31 | revenue | 270,967,000 United States dollar | superseded | [clm_F12D96426B16](/claim/clm_F12D96426B16.md)

## 2017

- 2017-02-10 to 2017-04-27 | shares_outstanding | 36,159,380 shares | superseded | [clm_A348EC1DFB72](/claim/clm_A348EC1DFB72.md)
- 2017-03-31 to 2017-06-30 | quarterly_operating_income | -8,000,000 United States dollar | superseded | [clm_0377055048CB](/claim/clm_0377055048CB.md)
- 2017-03-31 to 2017-06-30 | cash_and_equivalents | 69,786,000 United States dollar | superseded | [clm_3B7D8F12676B](/claim/clm_3B7D8F12676B.md)
- 2017-03-31 to 2017-06-30 | quarterly_revenue | 82,252,000 United States dollar | superseded | [clm_9168F25C3DCB](/claim/clm_9168F25C3DCB.md)
- 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 13,370,000 United States dollar | superseded | [clm_9623A36CB1EC](/claim/clm_9623A36CB1EC.md)
- 2017-03-31 to 2017-06-30 | total_equity | 124,343,000 United States dollar | superseded | [clm_A3DD6A2A3FC6](/claim/clm_A3DD6A2A3FC6.md)
- 2017-03-31 to 2017-06-30 | quarterly_net_income | -8,075,000 United States dollar | superseded | [clm_E3D676E0001A](/claim/clm_E3D676E0001A.md)
- 2017-03-31 to 2017-06-30 | total_assets | 275,281,000 United States dollar | superseded | [clm_ED0B4AA2CFBB](/claim/clm_ED0B4AA2CFBB.md)
- 2017-04-27 to 2017-07-27 | shares_outstanding | 36,555,873 shares | superseded | [clm_09A26F0830B9](/claim/clm_09A26F0830B9.md)
- 2017-06-30 to 2017-09-30 | cash_and_equivalents | 175,622,000 United States dollar | superseded | [clm_1B6698029134](/claim/clm_1B6698029134.md)
- 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 15,889,000 United States dollar | superseded | [clm_2B8664E5B900](/claim/clm_2B8664E5B900.md)
- 2017-06-30 to 2017-09-30 | quarterly_net_income | -9,521,000 United States dollar | superseded | [clm_4CC47D4C182E](/claim/clm_4CC47D4C182E.md)
- 2017-06-30 to 2017-09-30 | quarterly_operating_income | -10,577,000 United States dollar | superseded | [clm_75B65FCFAB4E](/claim/clm_75B65FCFAB4E.md)
- 2017-06-30 to 2017-09-30 | total_equity | 203,703,000 United States dollar | superseded | [clm_CE94B39BC713](/claim/clm_CE94B39BC713.md)
- 2017-06-30 to 2017-09-30 | quarterly_revenue | 89,093,000 United States dollar | superseded | [clm_D4D59812FAE6](/claim/clm_D4D59812FAE6.md)
- 2017-06-30 to 2017-09-30 | total_assets | 667,519,000 United States dollar | superseded | [clm_D6816E3D3225](/claim/clm_D6816E3D3225.md)
- 2017-07-27 to 2017-10-26 | shares_outstanding | 37,025,599 shares | superseded | [clm_DDA29B2E452A](/claim/clm_DDA29B2E452A.md)
- 2017-09-30 to 2017-12-31 | total_equity | 208,536,000 United States dollar | superseded | [clm_18BE73DFA07D](/claim/clm_18BE73DFA07D.md)
- 2017-09-30 to 2017-12-31 | total_assets | 686,326,000 United States dollar | superseded | [clm_2DCB7F94BB1F](/claim/clm_2DCB7F94BB1F.md)
- 2017-09-30 to 2018-03-31 | quarterly_net_income | -10,583,000 United States dollar | superseded | [clm_88B4A6FD3CBB](/claim/clm_88B4A6FD3CBB.md)
- 2017-09-30 to 2017-12-31 | cash_and_equivalents | 176,743,000 United States dollar | superseded | [clm_8ED1CB7C7204](/claim/clm_8ED1CB7C7204.md)
- 2017-09-30 to 2018-03-31 | quarterly_operating_income | -12,126,000 United States dollar | superseded | [clm_AE709B5D6482](/claim/clm_AE709B5D6482.md)
- 2017-09-30 to 2018-03-31 | quarterly_revenue | 97,726,000 United States dollar | superseded | [clm_CA6F3D31F6DE](/claim/clm_CA6F3D31F6DE.md)
- 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 18,828,000 United States dollar | superseded | [clm_D04FAC6089B8](/claim/clm_D04FAC6089B8.md)
- 2017-10-26 to 2018-02-07 | shares_outstanding | 37,371,546 shares | superseded | [clm_C799B76BC20A](/claim/clm_C799B76BC20A.md)
- 2017-12-31 to 2018-12-31 | revenue | 375,612,000 United States dollar | superseded | [clm_0C938B461032](/claim/clm_0C938B461032.md)
- 2017-12-31 to 2018-03-31 | total_equity | 210,360,000 United States dollar | superseded | [clm_10218B50EB40](/claim/clm_10218B50EB40.md)
- 2017-12-31 to 2018-12-31 | research_and_development | 70,373,000 United States dollar | superseded | [clm_1646ACF89838](/claim/clm_1646ACF89838.md)
- 2017-12-31 to 2018-03-31 | cash_and_equivalents | 87,680,000 United States dollar | superseded | [clm_6C4707B72870](/claim/clm_6C4707B72870.md)
- 2017-12-31 to 2018-12-31 | operating_income | -40,136,000 United States dollar | superseded | [clm_6DC9BAEC38C3](/claim/clm_6DC9BAEC38C3.md)
- 2017-12-31 to 2018-12-31 | net_income | -39,714,000 United States dollar | superseded | [clm_9A6E779AD483](/claim/clm_9A6E779AD483.md)
- 2017-12-31 to 2018-03-31 | total_assets | 712,175,000 United States dollar | superseded | [clm_D81051B1A4C1](/claim/clm_D81051B1A4C1.md)

## 2018

- 2018-02-07 to 2018-04-30 | shares_outstanding | 37,858,197 shares | superseded | [clm_33E4E1D93925](/claim/clm_33E4E1D93925.md)
- 2018-03-31 to 2018-06-30 | quarterly_net_income | -15,448,000 United States dollar | superseded | [clm_1FFAF6917B87](/claim/clm_1FFAF6917B87.md)
- 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 26,352,000 United States dollar | superseded | [clm_646BF376488A](/claim/clm_646BF376488A.md)
- 2018-03-31 to 2018-06-30 | total_equity | 221,098,000 United States dollar | superseded | [clm_77B0F39EC064](/claim/clm_77B0F39EC064.md)
- 2018-03-31 to 2018-06-30 | quarterly_revenue | 114,556,000 United States dollar | superseded | [clm_8ADB6F4E5E03](/claim/clm_8ADB6F4E5E03.md)
- 2018-03-31 to 2018-06-30 | total_assets | 742,975,000 United States dollar | superseded | [clm_BB28D24A5DFE](/claim/clm_BB28D24A5DFE.md)
- 2018-03-31 to 2018-06-30 | quarterly_operating_income | -11,324,000 United States dollar | superseded | [clm_CB08E7BE2D9C](/claim/clm_CB08E7BE2D9C.md)
- 2018-03-31 to 2018-06-30 | cash_and_equivalents | 154,031,000 United States dollar | superseded | [clm_EA37135104FD](/claim/clm_EA37135104FD.md)
- 2018-04-30 to 2018-07-27 | shares_outstanding | 38,409,346 shares | superseded | [clm_910F7A7BDA74](/claim/clm_910F7A7BDA74.md)
- 2018-06-30 to 2018-09-30 | cash_and_equivalents | 98,426,000 United States dollar | superseded | [clm_1E9352B86E73](/claim/clm_1E9352B86E73.md)
- 2018-06-30 to 2018-09-30 | quarterly_net_income | -18,225,000 United States dollar | superseded | [clm_401193D01FE8](/claim/clm_401193D01FE8.md)
- 2018-06-30 to 2018-09-30 | quarterly_operating_income | -14,052,000 United States dollar | superseded | [clm_4D91BA32FF29](/claim/clm_4D91BA32FF29.md)
- 2018-06-30 to 2018-09-30 | total_assets | 764,821,000 United States dollar | superseded | [clm_4E292488C014](/claim/clm_4E292488C014.md)
- 2018-06-30 to 2018-09-30 | quarterly_revenue | 122,576,000 United States dollar | superseded | [clm_9BBCCEC106FE](/claim/clm_9BBCCEC106FE.md)
- 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 28,485,000 United States dollar | superseded | [clm_B5581486CB5B](/claim/clm_B5581486CB5B.md)
- 2018-06-30 to 2018-09-30 | total_equity | 227,639,000 United States dollar | superseded | [clm_C91AA864D5B6](/claim/clm_C91AA864D5B6.md)
- 2018-07-27 to 2018-11-02 | shares_outstanding | 38,793,031 shares | superseded | [clm_4F27A96DA88F](/claim/clm_4F27A96DA88F.md)
- 2018-09-30 to 2018-12-31 | cash_and_equivalents | 96,122,000 United States dollar | superseded | [clm_18123A9A7904](/claim/clm_18123A9A7904.md)
- 2018-09-30 to 2018-12-31 | total_assets | 785,648,000 United States dollar | superseded | [clm_327C72229588](/claim/clm_327C72229588.md)
- 2018-09-30 to 2018-12-31 | total_equity | 229,413,000 United States dollar | superseded | [clm_35CC001DB899](/claim/clm_35CC001DB899.md)
- 2018-09-30 to 2019-03-31 | quarterly_net_income | -18,663,000 United States dollar | superseded | [clm_9C8C53C87C80](/claim/clm_9C8C53C87C80.md)
- 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 30,761,000 United States dollar | superseded | [clm_ACBC7D7ECC5A](/claim/clm_ACBC7D7ECC5A.md)
- 2018-09-30 to 2019-03-31 | quarterly_operating_income | -15,050,000 United States dollar | superseded | [clm_C0BA7F93AA1E](/claim/clm_C0BA7F93AA1E.md)
- 2018-09-30 to 2019-03-31 | quarterly_revenue | 131,826,000 United States dollar | superseded | [clm_D1D795F4C876](/claim/clm_D1D795F4C876.md)
- 2018-11-02 to 2019-02-11 | shares_outstanding | 39,232,269 shares | superseded | [clm_CA7A044AD573](/claim/clm_CA7A044AD573.md)
- 2018-12-31 to 2019-03-31 | cash_and_equivalents | 111,489,000 United States dollar | superseded | [clm_30131F8392A9](/claim/clm_30131F8392A9.md)
- 2018-12-31 to 2019-12-31 | revenue | 512,980,000 United States dollar | superseded | [clm_40B0F8FE1E1F](/claim/clm_40B0F8FE1E1F.md)
- 2018-12-31 to 2019-12-31 | net_income | -63,828,000 United States dollar | superseded | [clm_42D30E8895A1](/claim/clm_42D30E8895A1.md)
- 2018-12-31 to 2019-03-31 | total_equity | 244,641,000 United States dollar | superseded | [clm_859D5A70A959](/claim/clm_859D5A70A959.md)
- 2018-12-31 to 2019-03-31 | total_assets | 833,953,000 United States dollar | superseded | [clm_D06AE698A29C](/claim/clm_D06AE698A29C.md)
- 2018-12-31 to 2019-12-31 | research_and_development | 117,603,000 United States dollar | superseded | [clm_D2BBF310507C](/claim/clm_D2BBF310507C.md)
- 2018-12-31 to 2019-12-31 | operating_income | -48,258,000 United States dollar | superseded | [clm_E31A4E949744](/claim/clm_E31A4E949744.md)

## 2019

- 2019-02-11 to 2019-05-01 | shares_outstanding | 39,613,020 shares | superseded | [clm_673174EEEADC](/claim/clm_673174EEEADC.md)
- 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 35,177,000 United States dollar | superseded | [clm_151F1D64D952](/claim/clm_151F1D64D952.md)
- 2019-03-31 to 2019-06-30 | quarterly_net_income | -11,100,000 United States dollar | superseded | [clm_693C3C34F03A](/claim/clm_693C3C34F03A.md)
- 2019-03-31 to 2019-06-30 | total_equity | 599,003,000 United States dollar | superseded | [clm_72D4A94ECEB4](/claim/clm_72D4A94ECEB4.md)
- 2019-03-31 to 2019-06-30 | quarterly_operating_income | -9,036,000 United States dollar | superseded | [clm_8BFFDA665E0B](/claim/clm_8BFFDA665E0B.md)
- 2019-03-31 to 2019-06-30 | quarterly_revenue | 151,798,000 United States dollar | superseded | [clm_A0F3B3ED1BA4](/claim/clm_A0F3B3ED1BA4.md)
- 2019-03-31 to 2019-06-30 | total_assets | 1,370,125,000 United States dollar | superseded | [clm_D1D2E2221D2E](/claim/clm_D1D2E2221D2E.md)
- 2019-03-31 to 2019-06-30 | cash_and_equivalents | 285,126,000 United States dollar | superseded | [clm_DAF57989D18D](/claim/clm_DAF57989D18D.md)
- 2019-05-01 to 2019-08-01 | shares_outstanding | 42,103,120 shares | superseded | [clm_BABFECBA9994](/claim/clm_BABFECBA9994.md)
- 2019-06-30 to 2019-09-30 | total_equity | 618,144,000 United States dollar | superseded | [clm_325298C6AE86](/claim/clm_325298C6AE86.md)
- 2019-06-30 to 2019-09-30 | quarterly_net_income | -17,357,000 United States dollar | superseded | [clm_8982E7CF57C5](/claim/clm_8982E7CF57C5.md)
- 2019-06-30 to 2019-09-30 | total_assets | 1,463,492,000 United States dollar | superseded | [clm_9B06C28BC64A](/claim/clm_9B06C28BC64A.md)
- 2019-06-30 to 2019-09-30 | cash_and_equivalents | 238,080,000 United States dollar | superseded | [clm_BEFF36B8F8EE](/claim/clm_BEFF36B8F8EE.md)
- 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 40,456,000 United States dollar | superseded | [clm_CC15878F3461](/claim/clm_CC15878F3461.md)
- 2019-06-30 to 2019-09-30 | quarterly_revenue | 163,255,000 United States dollar | superseded | [clm_DE47F7A4B639](/claim/clm_DE47F7A4B639.md)
- 2019-06-30 to 2019-09-30 | quarterly_operating_income | -15,725,000 United States dollar | superseded | [clm_E6AE285B98C1](/claim/clm_E6AE285B98C1.md)
- 2019-08-01 to 2019-11-01 | shares_outstanding | 42,500,267 shares | superseded | [clm_C49FBBA0D36F](/claim/clm_C49FBBA0D36F.md)
- 2019-09-30 to 2019-12-31 | total_assets | 1,478,881,000 United States dollar | superseded | [clm_3B882792E314](/claim/clm_3B882792E314.md)
- 2019-09-30 to 2020-03-31 | quarterly_operating_income | -14,072,000 United States dollar | superseded | [clm_493A9E529AFE](/claim/clm_493A9E529AFE.md)
- 2019-09-30 to 2020-03-31 | quarterly_revenue | 173,621,000 United States dollar | superseded | [clm_580381AAA655](/claim/clm_580381AAA655.md)
- 2019-09-30 to 2019-12-31 | total_equity | 628,352,000 United States dollar | superseded | [clm_7F5B14B9CCE3](/claim/clm_7F5B14B9CCE3.md)
- 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 39,847,000 United States dollar | superseded | [clm_7FC07C732C0B](/claim/clm_7FC07C732C0B.md)
- 2019-09-30 to 2019-12-31 | cash_and_equivalents | 225,770,000 United States dollar | superseded | [clm_A5790992BE0B](/claim/clm_A5790992BE0B.md)
- 2019-09-30 to 2020-03-31 | quarterly_net_income | -14,987,000 United States dollar | superseded | [clm_F9911B68E9A1](/claim/clm_F9911B68E9A1.md)
- 2019-11-01 to 2020-02-07 | shares_outstanding | 42,821,424 shares | superseded | [clm_69A234C15BFC](/claim/clm_69A234C15BFC.md)
- 2019-12-31 to 2020-12-31 | operating_income | -46,991,000 United States dollar | superseded | [clm_4E79DEF98F7B](/claim/clm_4E79DEF98F7B.md)
- 2019-12-31 to 2020-12-31 | research_and_development | 158,237,000 United States dollar | superseded | [clm_534E0088F05F](/claim/clm_534E0088F05F.md)
- 2019-12-31 to 2020-03-31 | total_equity | 649,958,000 United States dollar | superseded | [clm_7A500E69CF0E](/claim/clm_7A500E69CF0E.md)
- 2019-12-31 to 2020-03-31 | cash_and_equivalents | 269,670,000 United States dollar | superseded | [clm_885FDD235319](/claim/clm_885FDD235319.md)
- 2019-12-31 to 2020-03-31 | total_assets | 1,569,268,000 United States dollar | superseded | [clm_BFB3474E635D](/claim/clm_BFB3474E635D.md)
- 2019-12-31 to 2020-12-31 | revenue | 674,860,000 United States dollar | superseded | [clm_C77E4DA74F83](/claim/clm_C77E4DA74F83.md)
- 2019-12-31 to 2020-12-31 | net_income | -53,746,000 United States dollar | superseded | [clm_D13501D1123D](/claim/clm_D13501D1123D.md)

## 2020

- 2020-02-07 to 2020-05-01 | shares_outstanding | 43,287,812 shares | superseded | [clm_783262CA22CA](/claim/clm_783262CA22CA.md)
- 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 46,202,000 United States dollar | superseded | [clm_40FB3D1B32A6](/claim/clm_40FB3D1B32A6.md)
- 2020-03-31 to 2020-06-30 | total_equity | 660,973,000 United States dollar | superseded | [clm_68644405431E](/claim/clm_68644405431E.md)
- 2020-03-31 to 2020-06-30 | quarterly_revenue | 198,968,000 United States dollar | superseded | [clm_7EF2EBBEFD47](/claim/clm_7EF2EBBEFD47.md)
- 2020-03-31 to 2020-06-30 | total_assets | 1,586,510,000 United States dollar | superseded | [clm_A03EEB3B2376](/claim/clm_A03EEB3B2376.md)
- 2020-03-31 to 2020-06-30 | cash_and_equivalents | 229,133,000 United States dollar | superseded | [clm_A48E01F6050A](/claim/clm_A48E01F6050A.md)
- 2020-03-31 to 2020-06-30 | quarterly_net_income | -17,716,000 United States dollar | superseded | [clm_B860244CA806](/claim/clm_B860244CA806.md)
- 2020-03-31 to 2020-06-30 | quarterly_operating_income | -14,102,000 United States dollar | superseded | [clm_FF859793A029](/claim/clm_FF859793A029.md)
- 2020-05-01 to 2020-07-31 | shares_outstanding | 43,627,128 shares | superseded | [clm_7EB10E841463](/claim/clm_7EB10E841463.md)
- 2020-06-30 to 2020-09-30 | quarterly_net_income | -29,401,000 United States dollar | superseded | [clm_0EC05AE7499C](/claim/clm_0EC05AE7499C.md)
- 2020-06-30 to 2020-09-30 | total_equity | 723,051,000 United States dollar | superseded | [clm_22E310F0767F](/claim/clm_22E310F0767F.md)
- 2020-06-30 to 2020-09-30 | cash_and_equivalents | 201,086,000 United States dollar | superseded | [clm_2D57022A504C](/claim/clm_2D57022A504C.md)
- 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 49,372,000 United States dollar | superseded | [clm_6919A42CB0DA](/claim/clm_6919A42CB0DA.md)
- 2020-06-30 to 2020-09-30 | quarterly_revenue | 203,608,000 United States dollar | superseded | [clm_818063DFC6F4](/claim/clm_818063DFC6F4.md)
- 2020-06-30 to 2020-09-30 | quarterly_operating_income | -13,625,000 United States dollar | superseded | [clm_D3C52BC9A6C3](/claim/clm_D3C52BC9A6C3.md)
- 2020-06-30 to 2020-09-30 | total_assets | 1,810,976,000 United States dollar | superseded | [clm_E73EFE869CED](/claim/clm_E73EFE869CED.md)
- 2020-07-31 to 2020-10-30 | shares_outstanding | 45,564,119 shares | superseded | [clm_935F5A05CA99](/claim/clm_935F5A05CA99.md)
- 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 54,456,000 United States dollar | superseded | [clm_15873244BDAF](/claim/clm_15873244BDAF.md)
- 2020-09-30 to 2021-03-31 | quarterly_net_income | -22,498,000 United States dollar | superseded | [clm_1EB9C48EC851](/claim/clm_1EB9C48EC851.md)
- 2020-09-30 to 2021-03-31 | quarterly_operating_income | -15,461,000 United States dollar | superseded | [clm_21650551B3A2](/claim/clm_21650551B3A2.md)
- 2020-09-30 to 2020-12-31 | total_assets | 1,875,421,000 United States dollar | superseded | [clm_229E5C02361D](/claim/clm_229E5C02361D.md)
- 2020-09-30 to 2020-12-31 | total_equity | 732,864,000 United States dollar | superseded | [clm_5655F076999B](/claim/clm_5655F076999B.md)
- 2020-09-30 to 2020-12-31 | cash_and_equivalents | 124,895,000 United States dollar | superseded | [clm_BCDB4762F15C](/claim/clm_BCDB4762F15C.md)
- 2020-09-30 to 2021-03-31 | quarterly_revenue | 228,385,000 United States dollar | superseded | [clm_C0DCB4CADA1F](/claim/clm_C0DCB4CADA1F.md)
- 2020-10-30 to 2021-02-12 | shares_outstanding | 45,887,624 shares | superseded | [clm_F45A9E70A21C](/claim/clm_F45A9E70A21C.md)
- 2020-12-31 to 2021-12-31 | net_income | -85,031,000 United States dollar | superseded | [clm_485724221050](/claim/clm_485724221050.md)
- 2020-12-31 to 2021-03-31 | total_assets | 1,973,366,000 United States dollar | superseded | [clm_4BF8E5526526](/claim/clm_4BF8E5526526.md)
- 2020-12-31 to 2021-12-31 | research_and_development | 205,589,000 United States dollar | superseded | [clm_585871612679](/claim/clm_585871612679.md)
- 2020-12-31 to 2021-03-31 | total_equity | 762,655,000 United States dollar | superseded | [clm_AF739C239677](/claim/clm_AF739C239677.md)
- 2020-12-31 to 2021-12-31 | revenue | 883,026,000 United States dollar | superseded | [clm_B10CD12DE49F](/claim/clm_B10CD12DE49F.md)
- 2020-12-31 to 2021-03-31 | cash_and_equivalents | 378,123,000 United States dollar | superseded | [clm_DC57336EADF9](/claim/clm_DC57336EADF9.md)
- 2020-12-31 to 2021-12-31 | operating_income | -50,828,000 United States dollar | superseded | [clm_FE4F7994B53D](/claim/clm_FE4F7994B53D.md)

## 2021

- 2021-02-12 to 2021-04-30 | shares_outstanding | 46,335,184 shares | superseded | [clm_93EB6A204C0B](/claim/clm_93EB6A204C0B.md)
- 2021-03-31 to 2021-06-30 | quarterly_revenue | 281,365,000 United States dollar | superseded | [clm_1ECD21DD3065](/claim/clm_1ECD21DD3065.md)
- 2021-03-31 to 2021-06-30 | quarterly_operating_income | -15,032,000 United States dollar | superseded | [clm_261C6DC76B00](/claim/clm_261C6DC76B00.md)
- 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 68,396,000 United States dollar | superseded | [clm_2B9D227F79AC](/claim/clm_2B9D227F79AC.md)
- 2021-03-31 to 2021-06-30 | total_equity | 774,714,000 United States dollar | superseded | [clm_6A5C0C1B3B85](/claim/clm_6A5C0C1B3B85.md)
- 2021-03-31 to 2021-06-30 | total_assets | 1,969,817,000 United States dollar | superseded | [clm_855D9071145A](/claim/clm_855D9071145A.md)
- 2021-03-31 to 2021-06-30 | quarterly_net_income | -23,159,000 United States dollar | superseded | [clm_8D57BBA25B2F](/claim/clm_8D57BBA25B2F.md)
- 2021-03-31 to 2021-06-30 | cash_and_equivalents | 397,498,000 United States dollar | superseded | [clm_E054C46CAFED](/claim/clm_E054C46CAFED.md)
- 2021-04-30 to 2021-07-30 | shares_outstanding | 46,725,776 shares | superseded | [clm_BD9688E1837F](/claim/clm_BD9688E1837F.md)
- 2021-06-30 to 2021-09-30 | quarterly_net_income | -24,572,000 United States dollar | superseded | [clm_1D2195BBCBDD](/claim/clm_1D2195BBCBDD.md)
- 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 72,104,000 United States dollar | superseded | [clm_1E729B262993](/claim/clm_1E729B262993.md)
- 2021-06-30 to 2021-09-30 | total_equity | 805,684,000 United States dollar | superseded | [clm_1FEF3F9F61F4](/claim/clm_1FEF3F9F61F4.md)
- 2021-06-30 to 2021-09-30 | quarterly_revenue | 310,788,000 United States dollar | superseded | [clm_394B21D8E61C](/claim/clm_394B21D8E61C.md)
- 2021-06-30 to 2021-09-30 | total_assets | 2,018,612,000 United States dollar | superseded | [clm_A98C6238A738](/claim/clm_A98C6238A738.md)
- 2021-06-30 to 2021-09-30 | quarterly_operating_income | -16,602,000 United States dollar | superseded | [clm_AA5F3EB41D98](/claim/clm_AA5F3EB41D98.md)
- 2021-06-30 to 2021-09-30 | cash_and_equivalents | 338,336,000 United States dollar | superseded | [clm_DEDB222B90B5](/claim/clm_DEDB222B90B5.md)
- 2021-07-30 to 2021-10-29 | shares_outstanding | 47,005,359 shares | superseded | [clm_41F22D7BFF7C](/claim/clm_41F22D7BFF7C.md)
- 2021-09-07 | ceo | Yamini Rangan | valid | [clm_3552FD3B9360](/claim/clm_3552FD3B9360.md)
- 2021-09-30 to 2021-12-31 | total_assets | 2,065,475,000 United States dollar | superseded | [clm_619EEECFB2E4](/claim/clm_619EEECFB2E4.md)
- 2021-09-30 to 2022-03-31 | quarterly_operating_income | -14,927,000 United States dollar | superseded | [clm_68856BE40B66](/claim/clm_68856BE40B66.md)
- 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 78,473,000 United States dollar | superseded | [clm_A74D00855D43](/claim/clm_A74D00855D43.md)
- 2021-09-30 to 2021-12-31 | total_equity | 831,993,000 United States dollar | superseded | [clm_D7E4E0F9F1EC](/claim/clm_D7E4E0F9F1EC.md)
- 2021-09-30 to 2021-12-31 | cash_and_equivalents | 288,334,000 United States dollar | superseded | [clm_D8496F64D5EF](/claim/clm_D8496F64D5EF.md)
- 2021-09-30 to 2022-03-31 | quarterly_revenue | 339,195,000 United States dollar | superseded | [clm_E8FAE7F57199](/claim/clm_E8FAE7F57199.md)
- 2021-09-30 to 2022-03-31 | quarterly_net_income | -13,735,000 United States dollar | superseded | [clm_EF75D5622383](/claim/clm_EF75D5622383.md)
- 2021-10-29 to 2022-02-11 | shares_outstanding | 47,249,897 shares | superseded | [clm_15DF4C768212](/claim/clm_15DF4C768212.md)
- 2021-12-31 to 2022-03-31 | cash_and_equivalents | 377,013,000 United States dollar | superseded | [clm_07267B7A0757](/claim/clm_07267B7A0757.md)
- 2021-12-31 to 2022-12-31 | revenue | 1,300,658,000 United States dollar | superseded | [clm_7E67B14315DA](/claim/clm_7E67B14315DA.md)
- 2021-12-31 to 2022-12-31 | operating_income | -54,799,000 United States dollar | superseded | [clm_97DDE9265A9F](/claim/clm_97DDE9265A9F.md)
- 2021-12-31 to 2022-03-31 | total_equity | 873,799,000 United States dollar | superseded | [clm_C10EE4776572](/claim/clm_C10EE4776572.md)
- 2021-12-31 to 2022-12-31 | net_income | -77,837,000 United States dollar | superseded | [clm_DB2CF1976FC7](/claim/clm_DB2CF1976FC7.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 301,970,000 United States dollar | superseded | [clm_DB71ADCB8F67](/claim/clm_DB71ADCB8F67.md)
- 2021-12-31 to 2022-03-31 | total_assets | 2,174,854,000 United States dollar | superseded | [clm_F541F9F7902B](/claim/clm_F541F9F7902B.md)

## 2022

- 2022-02-11 to 2022-04-29 | shares_outstanding | 47,569,390 shares | superseded | [clm_361CABA99CC6](/claim/clm_361CABA99CC6.md)
- 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 92,736,000 United States dollar | superseded | [clm_0CB7FFF4FCBE](/claim/clm_0CB7FFF4FCBE.md)
- 2022-03-31 to 2022-06-30 | quarterly_revenue | 395,599,000 United States dollar | superseded | [clm_10BD7251EEB0](/claim/clm_10BD7251EEB0.md)
- 2022-03-31 to 2022-06-30 | quarterly_net_income | -9,341,000 United States dollar | superseded | [clm_6417E33D1EE4](/claim/clm_6417E33D1EE4.md)
- 2022-03-31 to 2022-06-30 | cash_and_equivalents | 408,433,000 United States dollar | superseded | [clm_97C03CFC4A47](/claim/clm_97C03CFC4A47.md)
- 2022-03-31 to 2022-06-30 | total_assets | 2,253,302,000 United States dollar | superseded | [clm_A6784A9942AA](/claim/clm_A6784A9942AA.md)
- 2022-03-31 to 2022-06-30 | total_equity | 833,836,000 United States dollar | superseded | [clm_E21B771BEFC5](/claim/clm_E21B771BEFC5.md)
- 2022-03-31 to 2022-06-30 | quarterly_operating_income | -11,154,000 United States dollar | superseded | [clm_E68A18834965](/claim/clm_E68A18834965.md)
- 2022-04-29 to 2022-07-29 | shares_outstanding | 47,769,055 shares | superseded | [clm_B7A51008F3D2](/claim/clm_B7A51008F3D2.md)
- 2022-06-30 to 2022-09-30 | total_assets | 2,273,959,000 United States dollar | superseded | [clm_1F2B2CAB1484](/claim/clm_1F2B2CAB1484.md)
- 2022-06-30 to 2022-09-30 | quarterly_net_income | -56,361,000 United States dollar | superseded | [clm_7E46A604166A](/claim/clm_7E46A604166A.md)
- 2022-06-30 to 2022-09-30 | quarterly_operating_income | -52,250,000 United States dollar | superseded | [clm_9C15D89CA4A7](/claim/clm_9C15D89CA4A7.md)
- 2022-06-30 to 2022-09-30 | quarterly_revenue | 421,755,000 United States dollar | superseded | [clm_B3D8E3D7EEC8](/claim/clm_B3D8E3D7EEC8.md)
- 2022-06-30 to 2022-09-30 | cash_and_equivalents | 305,664,000 United States dollar | superseded | [clm_BB91F6348511](/claim/clm_BB91F6348511.md)
- 2022-06-30 to 2022-09-30 | total_equity | 871,467,000 United States dollar | superseded | [clm_DE5274BBB198](/claim/clm_DE5274BBB198.md)
- 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 118,914,000 United States dollar | superseded | [clm_F3479B8D2443](/claim/clm_F3479B8D2443.md)
- 2022-07-29 to 2022-10-28 | shares_outstanding | 48,019,203 shares | superseded | [clm_2E862CD6E997](/claim/clm_2E862CD6E997.md)
- 2022-09-30 to 2022-12-31 | cash_and_equivalents | 331,659,000 United States dollar | superseded | [clm_3EAF9715C0CB](/claim/clm_3EAF9715C0CB.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 443,958,000 United States dollar | superseded | [clm_4DE2D915FFB9](/claim/clm_4DE2D915FFB9.md)
- 2022-09-30 to 2022-12-31 | total_assets | 2,296,919,000 United States dollar | superseded | [clm_743E8B48323E](/claim/clm_743E8B48323E.md)
- 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 114,038,000 United States dollar | superseded | [clm_AE3FE9A3E1A0](/claim/clm_AE3FE9A3E1A0.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | -31,411,000 United States dollar | superseded | [clm_AED7478A40C2](/claim/clm_AED7478A40C2.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | -32,213,000 United States dollar | superseded | [clm_BAEE877D1A73](/claim/clm_BAEE877D1A73.md)
- 2022-09-30 to 2022-12-31 | total_equity | 906,697,000 United States dollar | superseded | [clm_ED2E3832CAE3](/claim/clm_ED2E3832CAE3.md)
- 2022-10-28 to 2023-02-10 | shares_outstanding | 48,576,188 shares | superseded | [clm_FBB98455663F](/claim/clm_FBB98455663F.md)
- 2022-12-31 to 2023-12-31 | operating_income | -109,101,000 United States dollar | superseded | [clm_1EE213A16876](/claim/clm_1EE213A16876.md)
- 2022-12-31 to 2023-12-31 | net_income | -112,749,000 United States dollar | superseded | [clm_4297E953C78A](/claim/clm_4297E953C78A.md)
- 2022-12-31 to 2023-03-31 | total_assets | 2,544,738,000 United States dollar | superseded | [clm_4B1835614B0E](/claim/clm_4B1835614B0E.md)
- 2022-12-31 to 2023-03-31 | total_equity | 992,224,000 United States dollar | superseded | [clm_70D4643F94D8](/claim/clm_70D4643F94D8.md)
- 2022-12-31 to 2023-12-31 | revenue | 1,730,969,000 United States dollar | superseded | [clm_768B7DC61567](/claim/clm_768B7DC61567.md)
- 2022-12-31 to 2023-03-31 | cash_and_equivalents | 331,022,000 United States dollar | superseded | [clm_9A8A30D67D26](/claim/clm_9A8A30D67D26.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 442,022,000 United States dollar | superseded | [clm_D43EBDE4CF2E](/claim/clm_D43EBDE4CF2E.md)

## 2023

- 2023-02-10 to 2023-04-28 | shares_outstanding | 49,392,241 shares | superseded | [clm_8F534CFE7DC2](/claim/clm_8F534CFE7DC2.md)
- 2023-03-31 to 2023-06-30 | quarterly_operating_income | -44,767,000 United States dollar | superseded | [clm_1FBF349F59D5](/claim/clm_1FBF349F59D5.md)
- 2023-03-31 to 2023-06-30 | cash_and_equivalents | 325,159,000 United States dollar | superseded | [clm_620AFE79DD81](/claim/clm_620AFE79DD81.md)
- 2023-03-31 to 2023-06-30 | quarterly_net_income | -38,282,000 United States dollar | superseded | [clm_6ED6175BDDCD](/claim/clm_6ED6175BDDCD.md)
- 2023-03-31 to 2023-06-30 | total_equity | 1,046,379,000 United States dollar | superseded | [clm_7BCE8931DFD8](/claim/clm_7BCE8931DFD8.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 501,620,000 United States dollar | superseded | [clm_8083FF80FBE9](/claim/clm_8083FF80FBE9.md)
- 2023-03-31 to 2023-06-30 | total_assets | 2,643,793,000 United States dollar | superseded | [clm_D30AE9CB9FA6](/claim/clm_D30AE9CB9FA6.md)
- 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 127,683,000 United States dollar | superseded | [clm_D3F06A349938](/claim/clm_D3F06A349938.md)
- 2023-04-28 to 2023-07-28 | shares_outstanding | 49,638,689 shares | superseded | [clm_564621872225](/claim/clm_564621872225.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | -118,946,000 United States dollar | superseded | [clm_2AA2BBFF2930](/claim/clm_2AA2BBFF2930.md)
- 2023-06-30 to 2023-09-30 | total_equity | 1,082,465,000 United States dollar | superseded | [clm_5FA64E495DEC](/claim/clm_5FA64E495DEC.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 529,138,000 United States dollar | superseded | [clm_99A3FE3624EF](/claim/clm_99A3FE3624EF.md)
- 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 169,955,000 United States dollar | superseded | [clm_A26A34F94C96](/claim/clm_A26A34F94C96.md)
- 2023-06-30 to 2023-09-30 | cash_and_equivalents | 457,218,000 United States dollar | superseded | [clm_D7F4D2556230](/claim/clm_D7F4D2556230.md)
- 2023-06-30 to 2023-09-30 | total_assets | 2,729,095,000 United States dollar | superseded | [clm_EF5C8F8AC42B](/claim/clm_EF5C8F8AC42B.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | -118,499,000 United States dollar | superseded | [clm_F4DB201DEDDA](/claim/clm_F4DB201DEDDA.md)
- 2023-07-28 to 2023-11-03 | shares_outstanding | 50,015,326 shares | superseded | [clm_0AA661C88E84](/claim/clm_0AA661C88E84.md)
- 2023-09-05 | board_member | Andrew Anagnost | valid | [clm_B68F9C954B01](/claim/clm_B68F9C954B01.md)
- 2023-09-30 to 2023-12-31 | total_equity | 1,186,339,000 United States dollar | superseded | [clm_3A10CC06366A](/claim/clm_3A10CC06366A.md)
- 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 156,871,000 United States dollar | superseded | [clm_6AF48D0D00B0](/claim/clm_6AF48D0D00B0.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | -5,463,000 United States dollar | superseded | [clm_8019E41EF5AB](/claim/clm_8019E41EF5AB.md)
- 2023-09-30 to 2023-12-31 | total_assets | 2,815,648,000 United States dollar | superseded | [clm_8462F636DF97](/claim/clm_8462F636DF97.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 535,545,000 United States dollar | superseded | [clm_9DE609F6A67B](/claim/clm_9DE609F6A67B.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | -20,442,000 United States dollar | superseded | [clm_CB595700D3C6](/claim/clm_CB595700D3C6.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 557,557,000 United States dollar | superseded | [clm_FCEBD77086EA](/claim/clm_FCEBD77086EA.md)
- 2023-11-03 to 2024-02-09 | shares_outstanding | 50,330,543 shares | superseded | [clm_BE13C58CB9C7](/claim/clm_BE13C58CB9C7.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 617,745,000 United States dollar | superseded | [clm_334AF8449E02](/claim/clm_334AF8449E02.md)
- 2023-12-31 to 2024-03-31 | total_assets | 3,071,392,000 United States dollar | superseded | [clm_58053852607F](/claim/clm_58053852607F.md)
- 2023-12-31 to 2024-12-31 | revenue | 2,170,230,000 United States dollar | superseded | [clm_8708AFE1C21B](/claim/clm_8708AFE1C21B.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 387,987,000 United States dollar | superseded | [clm_A4B2E478CDCB](/claim/clm_A4B2E478CDCB.md)
- 2023-12-31 to 2024-03-31 | total_equity | 1,320,109,000 United States dollar | superseded | [clm_E0E6D0D5A5FD](/claim/clm_E0E6D0D5A5FD.md)
- 2023-12-31 to 2024-12-31 | net_income | -176,295,000 United States dollar | superseded | [clm_E95E33F6A695](/claim/clm_E95E33F6A695.md)
- 2023-12-31 to 2024-12-31 | operating_income | -208,056,000 United States dollar | superseded | [clm_F3DDDD652CAB](/claim/clm_F3DDDD652CAB.md)

## 2024

- 2024-02-09 to 2024-05-02 | shares_outstanding | 50,674,493 shares | superseded | [clm_DE63D807EF64](/claim/clm_DE63D807EF64.md)
- 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 175,637,000 United States dollar | superseded | [clm_1CF020D2B038](/claim/clm_1CF020D2B038.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 617,414,000 United States dollar | superseded | [clm_1F0695496B8A](/claim/clm_1F0695496B8A.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | -23,233,000 United States dollar | superseded | [clm_5EAA52830FBE](/claim/clm_5EAA52830FBE.md)
- 2024-03-31 to 2024-06-30 | quarterly_net_income | 5,934,000 United States dollar | superseded | [clm_6F7C162FE71F](/claim/clm_6F7C162FE71F.md)
- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 447,793,000 United States dollar | superseded | [clm_997D9B5F2334](/claim/clm_997D9B5F2334.md)
- 2024-03-31 to 2024-06-30 | total_assets | 3,193,103,000 United States dollar | superseded | [clm_AD7DC448BB1D](/claim/clm_AD7DC448BB1D.md)
- 2024-03-31 to 2024-06-30 | total_equity | 1,449,117,000 United States dollar | superseded | [clm_BCD1932B3336](/claim/clm_BCD1932B3336.md)
- 2024-05-02 to 2024-08-02 | shares_outstanding | 50,962,443 shares | superseded | [clm_F7F1CC5654FB](/claim/clm_F7F1CC5654FB.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 637,230,000 United States dollar | superseded | [clm_18CC9F3FEF8F](/claim/clm_18CC9F3FEF8F.md)
- 2024-06-30 to 2024-09-30 | total_assets | 3,356,002,000 United States dollar | superseded | [clm_4810B25F9971](/claim/clm_4810B25F9971.md)
- 2024-06-30 to 2024-09-30 | total_equity | 1,600,899,000 United States dollar | superseded | [clm_88F8A92D9F91](/claim/clm_88F8A92D9F91.md)
- 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 198,180,000 United States dollar | superseded | [clm_95B7FD5BD087](/claim/clm_95B7FD5BD087.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | -23,935,000 United States dollar | superseded | [clm_B06F821C2192](/claim/clm_B06F821C2192.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | -14,435,000 United States dollar | superseded | [clm_F3037AF599DB](/claim/clm_F3037AF599DB.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 797,875,000 United States dollar | superseded | [clm_FF7D5F2F3BC9](/claim/clm_FF7D5F2F3BC9.md)
- 2024-08-02 to 2024-11-01 | shares_outstanding | 51,348,838 shares | superseded | [clm_81C61C28CEA8](/claim/clm_81C61C28CEA8.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 669,721,000 United States dollar | superseded | [clm_1DF03F2C7104](/claim/clm_1DF03F2C7104.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 410,060,000 United States dollar | superseded | [clm_2853F960E66C](/claim/clm_2853F960E66C.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | 8,146,000 United States dollar | superseded | [clm_47D0405862E4](/claim/clm_47D0405862E4.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | -9,631,000 United States dollar | superseded | [clm_9B368A5B9DF6](/claim/clm_9B368A5B9DF6.md)
- 2024-09-30 to 2024-12-31 | total_assets | 3,557,058,000 United States dollar | superseded | [clm_9E2E5B17DC2B](/claim/clm_9E2E5B17DC2B.md)
- 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 191,185,000 United States dollar | superseded | [clm_A12D56AAF000](/claim/clm_A12D56AAF000.md)
- 2024-09-30 to 2024-12-31 | total_equity | 1,751,882,000 United States dollar | superseded | [clm_F3855FAB0E51](/claim/clm_F3855FAB0E51.md)
- 2024-11-01 to 2025-02-07 | shares_outstanding | 51,623,568 shares | superseded | [clm_4BC1E1A533C5](/claim/clm_4BC1E1A533C5.md)
- 2024-12-31 to 2025-12-31 | revenue | 2,627,543,000 United States dollar | superseded | [clm_115DDC8E79E0](/claim/clm_115DDC8E79E0.md)
- 2024-12-31 to 2025-12-31 | operating_income | -67,602,000 United States dollar | superseded | [clm_1541A59979F4](/claim/clm_1541A59979F4.md)
- 2024-12-31 to 2025-03-31 | total_assets | 3,795,833,000 United States dollar | superseded | [clm_1B1411EA5166](/claim/clm_1B1411EA5166.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 778,714,000 United States dollar | superseded | [clm_5229E6919019](/claim/clm_5229E6919019.md)
- 2024-12-31 to 2025-03-31 | total_equity | 1,908,286,000 United States dollar | superseded | [clm_7820B4B40F0E](/claim/clm_7820B4B40F0E.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 512,667,000 United States dollar | superseded | [clm_8E3C1835D87D](/claim/clm_8E3C1835D87D.md)
- 2024-12-31 to 2025-12-31 | net_income | 4,628,000 United States dollar | superseded | [clm_9769EB010A72](/claim/clm_9769EB010A72.md)
- 2024-12-31 to 2025-12-31 | employees | 8,246 | superseded | [clm_B334618C1A63](/claim/clm_B334618C1A63.md)

## 2025

- 2025-02-07 to 2025-05-02 | shares_outstanding | 52,153,077 shares | superseded | [clm_B667943AD08C](/claim/clm_B667943AD08C.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 625,029,000 United States dollar | superseded | [clm_1F569FB7AB3E](/claim/clm_1F569FB7AB3E.md)
- 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 220,100,000 United States dollar | superseded | [clm_3F922C670ED5](/claim/clm_3F922C670ED5.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | -27,480,000 United States dollar | superseded | [clm_616FBCEF444D](/claim/clm_616FBCEF444D.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | -21,793,000 United States dollar | superseded | [clm_7DB6AD9938AD](/claim/clm_7DB6AD9938AD.md)
- 2025-03-31 to 2025-06-30 | quarterly_revenue | 714,137,000 United States dollar | superseded | [clm_8717DD595A19](/claim/clm_8717DD595A19.md)
- 2025-03-31 to 2025-06-30 | total_equity | 2,004,544,000 United States dollar | superseded | [clm_A3EF9DA7EC77](/claim/clm_A3EF9DA7EC77.md)
- 2025-03-31 to 2025-06-30 | total_assets | 3,896,316,000 United States dollar | superseded | [clm_E49BD9C48C6C](/claim/clm_E49BD9C48C6C.md)
- 2025-05-02 to 2025-08-01 | shares_outstanding | 52,737,566 shares | superseded | [clm_A04B23A75DF4](/claim/clm_A04B23A75DF4.md)
- 2025-06-30 to 2025-09-30 | quarterly_net_income | -3,258,000 United States dollar | superseded | [clm_1463E0F425D9](/claim/clm_1463E0F425D9.md)
- 2025-06-30 to 2025-09-30 | total_equity | 2,065,056,000 United States dollar | superseded | [clm_3643A747DF73](/claim/clm_3643A747DF73.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 760,866,000 United States dollar | superseded | [clm_81FBDFB5A422](/claim/clm_81FBDFB5A422.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | -24,614,000 United States dollar | superseded | [clm_89C71E005B1D](/claim/clm_89C71E005B1D.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 601,196,000 United States dollar | superseded | [clm_9B7CC1CB2F91](/claim/clm_9B7CC1CB2F91.md)
- 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 237,340,000 United States dollar | superseded | [clm_E5B201204587](/claim/clm_E5B201204587.md)
- 2025-06-30 to 2025-09-30 | total_assets | 3,683,964,000 United States dollar | superseded | [clm_F4D2C71CA603](/claim/clm_F4D2C71CA603.md)
- 2025-08-01 to 2025-10-31 | shares_outstanding | 52,693,110 shares | superseded | [clm_52CC6809F407](/claim/clm_52CC6809F407.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | 16,536,000 United States dollar | superseded | [clm_227B13963D94](/claim/clm_227B13963D94.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 809,518,000 United States dollar | superseded | [clm_512454E8C12A](/claim/clm_512454E8C12A.md)
- 2025-09-30 to 2025-12-31 | total_assets | 3,502,358,000 United States dollar | superseded | [clm_60950A621B52](/claim/clm_60950A621B52.md)
- 2025-09-30 to 2025-12-31 | total_equity | 1,855,842,000 United States dollar | superseded | [clm_75800BCB1F99](/claim/clm_75800BCB1F99.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | 11,234,000 United States dollar | superseded | [clm_9B03C8F6089E](/claim/clm_9B03C8F6089E.md)
- 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 227,714,000 United States dollar | superseded | [clm_F6C32E349799](/claim/clm_F6C32E349799.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 614,352,000 United States dollar | superseded | [clm_F9D8EA62B9C6](/claim/clm_F9D8EA62B9C6.md)
- 2025-10-31 to 2026-02-06 | shares_outstanding | 52,385,551 shares | superseded | [clm_C8877822B39E](/claim/clm_C8877822B39E.md)
- 2025-11-03 | board_member | Clara Shih | valid | [clm_4512C26A8365](/claim/clm_4512C26A8365.md)
- 2025-12-31 to 2026-03-31 | total_equity | 2,066,244,000 United States dollar | superseded | [clm_1AC210C5F6F0](/claim/clm_1AC210C5F6F0.md)
- 2025-12-31 | employees | 8,882 | valid | [clm_276F2EEED18E](/claim/clm_276F2EEED18E.md)
- 2025-12-31 to 2026-03-31 | total_assets | 3,854,151,000 United States dollar | superseded | [clm_543A981C044C](/claim/clm_543A981C044C.md)
- 2025-12-31 | research_and_development | 905,943,000 United States dollar | valid | [clm_5E504DF1D768](/claim/clm_5E504DF1D768.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 882,242,000 United States dollar | superseded | [clm_81A2261B0852](/claim/clm_81A2261B0852.md)
- 2025-12-31 | operating_income | 7,379,000 United States dollar | valid | [clm_95C07EB67402](/claim/clm_95C07EB67402.md)
- 2025-12-31 | net_income | 45,911,000 United States dollar | valid | [clm_A14F7CFF4F8A](/claim/clm_A14F7CFF4F8A.md)
- 2025-12-31 | revenue | 3,131,266,000 United States dollar | valid | [clm_ABB39DD86703](/claim/clm_ABB39DD86703.md)

## 2026

- 2026-02-06 to 2026-05-01 | shares_outstanding | 52,740,536 shares | superseded | [clm_CCF00F8ACBA6](/claim/clm_CCF00F8ACBA6.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 880,995,000 United States dollar | superseded | [clm_192157F42788](/claim/clm_192157F42788.md)
- 2026-03-31 to 2026-06-30 | total_equity | 1,996,780,000 United States dollar | superseded | [clm_24A0987C9A39](/claim/clm_24A0987C9A39.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 943,937,000 United States dollar | superseded | [clm_5A1F8F31C3FE](/claim/clm_5A1F8F31C3FE.md)
- 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 234,193,000 United States dollar | superseded | [clm_631CCD019F00](/claim/clm_631CCD019F00.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | 27,943,000 United States dollar | superseded | [clm_88C0155A0878](/claim/clm_88C0155A0878.md)
- 2026-03-31 to 2026-06-30 | total_assets | 3,829,258,000 United States dollar | superseded | [clm_AF9F5165EC99](/claim/clm_AF9F5165EC99.md)
- 2026-03-31 to 2026-06-30 | quarterly_net_income | 32,554,000 United States dollar | superseded | [clm_ECFEEEB3ACF3](/claim/clm_ECFEEEB3ACF3.md)
- 2026-04-01 | board_member | Mike Berry | valid | [clm_E5ECB93B347B](/claim/clm_E5ECB93B347B.md)
- 2026-05-01 to 2026-07-31 | shares_outstanding | 51,217,740 shares | superseded | [clm_6ABB6CAE0207](/claim/clm_6ABB6CAE0207.md)
- 2026-06-30 | quarterly_revenue | 911,740,000 United States dollar | valid | [clm_1A1B508B7B12](/claim/clm_1A1B508B7B12.md)
- 2026-06-30 | quarterly_operating_income | 43,319,000 United States dollar | valid | [clm_2F71D6B45BE7](/claim/clm_2F71D6B45BE7.md)
- 2026-06-30 | quarterly_net_income | 43,338,000 United States dollar | valid | [clm_5ADC0C9F4C3D](/claim/clm_5ADC0C9F4C3D.md)
- 2026-06-30 | cash_and_equivalents | 958,314,000 United States dollar | valid | [clm_5E3D955920E4](/claim/clm_5E3D955920E4.md)
- 2026-06-30 | quarterly_research_and_development | 225,823,000 United States dollar | valid | [clm_66736368A52C](/claim/clm_66736368A52C.md)
- 2026-06-30 | total_equity | 1,656,728,000 United States dollar | valid | [clm_71C6EDD1F2FE](/claim/clm_71C6EDD1F2FE.md)
- 2026-06-30 | total_assets | 3,504,395,000 United States dollar | valid | [clm_C576B3202FC2](/claim/clm_C576B3202FC2.md)
- 2026-07-22 | partnership | TELUS Digital | valid | [clm_0B530DF3D75A](/claim/clm_0B530DF3D75A.md)
- 2026-07-23 | launched | Agent Builder | valid | [clm_1502D3B7489D](/claim/clm_1502D3B7489D.md)
- 2026-07-23 | launched | Agent Hub | valid | [clm_265CA67AD6D3](/claim/clm_265CA67AD6D3.md)
- 2026-07-31 | shares_outstanding | 49,866,201 shares | valid | [clm_514F4ED24059](/claim/clm_514F4ED24059.md)
- 2026-08-05 | board_member | Gerald Dischler | valid | [clm_A297C3B0A7DB](/claim/clm_A297C3B0A7DB.md)
- 2026-09-16 | partnership | [OpenAI](/record/openai.md) | valid | [clm_75256402BD9D](/claim/clm_75256402BD9D.md)
- 2026-10-01 | restructuring | Board-authorized workforce reduction eliminating roles, about 7% of workforce | valid | [clm_E697D3AC751A](/claim/clm_E697D3AC751A.md)
- 2026-10-15 | policy_changed | AI spend caps for customers | valid | [clm_9BD9F8CAB6AE](/claim/clm_9BD9F8CAB6AE.md)
- 2026-10-15 | policy_changed | seat-to-credit conversion self-serve | valid | [clm_AE2D885DB679](/claim/clm_AE2D885DB679.md)
- 2026-10-15 | price | Prepaid credit packs flat monthly rate | valid | [clm_E55C1FCF445E](/claim/clm_E55C1FCF445E.md)
- 2026-10-15 | price | Pay-as-You-Go credits option | valid | [clm_FD50D8ACDAED](/claim/clm_FD50D8ACDAED.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.